These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1017793)

  • 1. Failure of cyprohepatdine to inhibit vasopressin-stimulated cortisol release in a patient with Cushing's disease.
    George WF; Husain M; Lock JP; Katz FH
    Horm Res; 1976; 7(4-5):308-12. PubMed ID: 1017793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
    Krieger DT; Luria M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyproheptadine may act at the pituitary in Cushing's disease: evidence from CRF stimulation.
    Tucci JR; Nowakowski KJ; Jackson IM
    J Endocrinol Invest; 1989 Mar; 12(3):197-200. PubMed ID: 2542391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cyproheptadine-reversible defect in ACTH control persisting after removal of the pituitary tumor in Cushing's disease.
    Lankford HV; Tucker HS; Blackard WG
    N Engl J Med; 1981 Nov; 305(21):1244-8. PubMed ID: 6270557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of ACTH secretion control in 116 cases of Cushing's syndrome.
    Raux MC; Binoux M; Luton JP; Gourmelen M; Girard F
    J Clin Endocrinol Metab; 1975 Feb; 40(2):186-97. PubMed ID: 163970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rebound elevation of cortisol following cyproheptadine withdrawal in Cushing's disease from a pituitary macroadenoma.
    Ooi TC; Twum-Barima Y
    J Endocrinol Invest; 1987 Apr; 10(2):107-9. PubMed ID: 3584851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twelve-hour cycles of adrenocorticotropin and cortisol secretion in Cushing's disease.
    Schteingart DE; McKenzie AK
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1195-8. PubMed ID: 6252234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of propranolol on the response of blood cortisol to lysine-vasopressin and on the daily changes of blood cortisol in the diencephalo-hypophyscal Cushing's syndrome].
    Cugini P; Lupi A; Manconi R
    Boll Soc Ital Biol Sper; 1975 Dec; 51(23):1837-43. PubMed ID: 1231864
    [No Abstract]   [Full Text] [Related]  

  • 9. Cortisol secretory patterns in Cushing's disease and response to cyproheptadine treatment.
    van Waveren Hogervorst CO; Koppeschaar HP; Zelissen PM; Lips CJ; Garcia BM
    J Clin Endocrinol Metab; 1996 Feb; 81(2):652-5. PubMed ID: 8636284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual adrenocortical function after bilateral adrenalectomy for pituitary-dependent Cushing's syndrome.
    Kemink L; Hermus A; Pieters G; Benraad T; Smals A; Kloppenborg P
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1211-4. PubMed ID: 1331164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of cyproheptadine on plasma ACTH and cortisol secretion in a patient with Cushing's disease].
    Esposito V; D'Alessandro B; Bellastella A; Iacono G; Bizzarro A; Officioso A; Piccolo C
    Boll Soc Ital Biol Sper; 1976 Nov; 52(22):1901-5. PubMed ID: 194608
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship of bioassayable and immunoassayable plasma ACTH and cortisol concentrations in normal subjects and in patients with Cushing's disease.
    Krieger DT; Allen W
    J Clin Endocrinol Metab; 1975 Apr; 40(4):675-87. PubMed ID: 165214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRH in Cushing's syndrome.
    Müller OA; Stalla GK; von Werder K
    Horm Metab Res Suppl; 1987; 16():51-8. PubMed ID: 2832289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of Cushing's disease.
    Fehm HL; Voigt KH
    Pathobiol Annu; 1979; 9():225-55. PubMed ID: 225710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Cushing's syndrome: diurnal rhythm and responses to various stimuli.
    Orth DN; Peterson ME; Drucker WD
    Endocrinology; 1988 Apr; 122(4):1250-62. PubMed ID: 3126032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of antiserotoninergic and/or dopaminergic treatment in patients with pituitary-dependent Cushing's syndrome.
    Ambrosi B; Gaggini M; Secchi F; Faglia G
    Horm Metab Res; 1979 Apr; 11(4):318-9. PubMed ID: 222663
    [No Abstract]   [Full Text] [Related]  

  • 19. Dynamics of adrenocorticotropin (ACTH) secretion in cyclic Cushing's syndrome: evidence for more than one abnormal ACTH biorhythm.
    Jordan RM; Ramos-Gabatin A; Kendall JW; Gaudette D; Walls RC
    J Clin Endocrinol Metab; 1982 Sep; 55(3):531-7. PubMed ID: 6284783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium valproate and cyproheptadine may independently induce a remission in the same patient with Cushing's disease.
    Koppeschaar HP; Croughs RJ; Thijssen JH; Schwarz F
    Acta Endocrinol (Copenh); 1983 Oct; 104(2):160-3. PubMed ID: 6314723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.